Exposure of CV-1P cells to hypoxic conditions results in reversible cell cycle arrest concomitant with accumulation of pRB in the hypophosphorylated, growth suppressive form. Similar to cell cycle arrest induced by serum starvation, we show here that hypoxia-induced arrest is accompanied by a decrease in pRB-directed CDK4 and CDK2 activities, lower cyclin D and E protein levels, and by an increase in p27 protein abundance. Immunoprecipitation studies reveal an increase in p27 association with cyclin E-CDK2 complexes. In contrast to cell cycle arrest induced by serum starvation, hypoxia increases PP1-mediated pRB dephosphorylation. These data reveal that synergy between decreased pRB-directed cyclin/CDK activity and increased pRB-directed phosphatase activity contribute towards inducing and maintaining pRB in its hypophosphorylated, growth suppressive state during hypoxia.
Introduction
The growth suppressive activity of the product of the retinoblastoma susceptibility gene, pRB, is regulated by its phosphorylation state. pRB phosphorylation varies as a function of cell cycle phase; during G 1 the hypophosphorylated form predominates, while the hyperphosphorylated form accumulates during S, G 2 and M phase (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989) . It is this hypophosphorylated form of pRB present during early and mid G 1 which functions to modify gene expression. This is achieved by complexing with transcription factors resulting in repression (Nevins, 1992) or stimulation (Udvadia et al., 1995) of transcription. Under conditions favoring proliferation, the phosphorylation of pRB via cyclin-dependent kinases (CDKs) in midto-late G 1 phase results in liberation of E2F and other pRB-bound transcription factors, which then activate the transcription of S phase genes (reviewed in Bartek et al., 1996) . In late M phase, pRB returns to its growth suppressive, hypophosphorylated form due to the action of a pRB-directed protein phosphatase belonging to the type 1 class of serine/threonine protein phosphatases (PP1) (Ludlow et al., 1993a; .
It has been recently demonstrated (Connell-Crowley et al., 1997; Kitagawa et al., 1996; Knudsen and Wang, 1996 .) that phosphorylation on speci®c serine and threonine residues is required for inhibition of functionally distinct binding activities of pRB. Accumulating evidence implicates cyclin D-CDK4 as one of the kinase complexes which performs initial phosphorylation of pRB, thereby promoting mid-to-late G 1 progression. Cyclin E-CDK2 complexes are thought to be responsible for subsequent pRB phosphorylation required for G 1 to S phase transition (Geng et al., 1996; Hatakeyama et al., 1994; Sherr, 1994) . The discovery of CDK inhibitors (CKIs), which by association with active cyclin-CDK complexes further modulate their activity, has added an additional level of complexity to the understanding of cell cycle regulation. Divided into two families based on sequence homology and mode of action, p16/p15 members speci®cally inhibit CDK4, while members of the p21/p27 family inhibit all G 1 CDKs in vitro, including CDK2 (Hall et al., 1995; Serrano et al., 1993; Toyoshima and Hunter, 1994; Xiong et al., 1993) . Elevated levels of CKIs have been shown to cause G 1 arrest by inhibiting CDK activity. Such inhibition may facilitate accumulation of hypophosphorylated pRB, thereby prolonging the growth suppressing activity of this protein (Toyoshima and Hunter, 1994; Harper et al., 1993; Resnitsky et al., 1995) .
Overall cell proliferation is regulated in response to changes in the extracellular environment. For example, low oxygen availability, or hypoxia, causes an inhibition of the respiratory chain thereby lowering ATP synthesis by the cell (reviewed in Guillemin and Krasnow, 1997) . In accordance with the need by the cell to decrease energy usage under low oxygen conditions, hypoxia inhibits cell proliferation as well as general transcription and translation in multiple cell types (Graeber et al., 1994; Amellem and Pettersen, 1991; Heacock and Sutherland, 1990.) . Published work from our own laboratory and others is consistent with the hypothesis that the arrest of cellular proliferation by hypoxia involves disrupting the synthesis and degradation of cyclins, as well as the post-translational modi®cation of pRB (Amellem et al., 1996; Krotlica and Ludlow, 1996; Ludlow et al., 1993b) .
We previously reported that hypoxia-induced growth arrest results in accumulation of hypophosphorylated pRB in both transformed and non-transformed cells (Krotlica and Ludlow, 1996; Ludlow et al., 1993b) . The current study was undertaken determine the mechanism of hypoxia-induced pRB hypophosphorylation. As presented below, these data reveal that synergy between decreased pRB-directed cyclin/CDK activity and increased pRB-directed phosphatase activity contribute towards inducing and maintaining pRB in its hypophosphorylated, growth suppressive state during hypoxia.
Results

Hypoxia induced inhibition of proliferation
We have previously reported that eukaryotic cells cultured under hypoxic conditions remain viable but stop dividing (Krtolica and Ludlow, 1996; Ludlow et al., 1993b) . Flow cytometric analysis of CV-1P cellular DNA content revealed that, within 24 h of hypoxia, the percentage of cells found in S phase decreases signi®cantly (50 ± 70% in ®ve independent experiments) ( Figure 1A ). At the same time, a modest increase (10 ± 20% in ®ve independent experiments) in the percentage of G 1 cells can be observed. This suggests that CV-1P cells cultured under hypoxic conditions are not able to make the transition from G 1 to S phase of the cell cycle, and thus have stopped synthesis of DNA. This suggestion was supported by results from [ 3 H]thymidine incorporation assays which revealed that DNA synthesis was 50% lower after 18 h of hypoxia compared to the aerobic controls, and approximately 80% lower after 24 h of hypoxia ( Figure 1B ). Immunoblot analysis of pRB from lysate of hypoxia-exposed cells showed an increase in abundance of the growth suppressive, hypophosphorylated form of pRB (Figure 2 ) that is in agreement with our previous reports (Krtolica and Ludlow, 1996; Ludlow et al., 1993b) . Taken together, it appears that a major portion of hypoxic CV-1P cells are not able to make the transition from G 1 to S phase of the cell cycle and this inhibition is, within the ®rst 24 h of exposure, associated with hypophosphorylation of pRB. As such, we have concentrated on the G 1 cyclin/CDK complex activities in determining the mechanism of hypoxiainduced pRB hypophosphorylation.
CDK activity is downregulated during hypoxia
Accumulating evidence implicates cyclin D-CDK4 as one of the kinase complexes which performs initial phosphorylation of pRB, necessary for mid-to-late G 1 progression. Subsequent pRB phosphorylation required for G 1 to S phase transition is thought to be the result of cyclin E-CDK2 activity (Geng et al., 1996; Hatakeyama et al., 1994; Sherr, 1994) . To investigate whether the increase in hypophosphorylated pRB abundance during hypoxia can be attributed to a decrease in CDK activity, we performed in vitro kinase assays. Using histone H1 as the substrate under conditions inhibitory for other common general kinases, we ®rst determined the total CDK activity in cell lysates from hypoxic and aerobic cells. A slight, but reproducible, decrease in H1 phosphorylation activity in hypoxic cell lysates was found ( Figure 3A ). To address this issue more speci®cally, we tested whether hypoxia aects CDK4 and/or CDK2 activity. Since histones appear to be a poor substrate for CDK4 (Hatakeyama et al., 1994) , we used pRB as the substrate for CDK4 kinase assays and found that CDK4 activity towards pRB is decreased during hypoxia ( Figure 3B ). In addition, the overall abundance of cyclin D and CDK4 is also decreased in hypoxia, compared to the aerobic control ( Figure 4 ). p16, a demonstrated inhibitor of cyclin D- (Serrano et al., 1993) , was barely detectable in lysates from both aerobic and hypoxic cells. This suggests that the lower abundance of cyclin D and CDK4 may account for the observed decrease in CDK4 kinase activity towards pRB.
As mentioned above, cyclin E-CDK2 complexes are thought to be responsible for pRB phosphorylation required for the G 1 to S phase transition (Geng et al., 1996; Hatakeyama et al., 1994; Sherr, 1994) . In CDK2 kinase assays with histone H1 substrate, we observed a 34 ± 55% decrease in precipitable kinase activity from hypoxic cell lysates compared to the aerobic control ( Figure 5A , ®rst three lanes from the left). When pRB is used as the substrate, we found a 54 ± 65% decrease in CDK2-directed kinase activity ( Figure 5B ). We also performed kinase activity assays using cyclin E immunoprecipitates in parallel with activity assays of CDK2 immunocomplexes ( Figure 5A ). We detected a 46 ± 58% decrease in kinase activity for the cyclin E immunoprecipitates, comparable to those observed for CDK2 immunoprecipitates towards H1 and pRB. In summary, these results suggest hypoxia inhibits both cyclin D-CDK4 and cyclin E-CDK2 mediated phosphorylation of pRB.
Downregulation of CDK2 activity in hypoxia coincides with an increase in p27 association
A number of studies have suggested that p27 is a CDK2 inhibitor capable of inhibiting pRB phosphorylation by cyclin E/CDK2 complexes (Reynisdottir and MassagueÂ , 1997; Soos et al., 1996; Reynisdottir et al., 1995) . Our immunoblot analysis of CV-1P hypoxic cell lysates demonstrates that there is an overall increase in the level of p27 (with a peak of abundance at 18 h of hypoxia) and a slight decrease in cyclin E levels during the ®rst 24 h of hypoxia compared to the aerobic control ( Figure 6A ). CDK2 levels remain constant throughout the time course ( Figure 6A ), unlike the levels of CDK4 (see Figure 4) . These data are consistent with a scenario whereby p27 inhibition of active cyclin-CDK2 complexes, in addition to lower amounts of cyclin E available for active complex formation, can together result in the observed decrease in CDK2 activity during hypoxia.
To examine the potential role of p27 in the inhibition of CDK2 activity during hypoxia, we analysed CDK2 immunoprecipitates for the presence of p27 and regulatory cyclin subunits by probing with the corresponding monoclonal antibodies. Our data reveal that during hypoxia there is a speci®c association of p27 with cyclin E/CDK2 complexes that is not present in aerobic cell lysate immunoprecipitates ( Figure 6A ). Moreover, co-precipitation of the complex using anti-cyclin E antibody identi®ed p27 associated with cyclin E-CDK2 complex only during hypoxia, with a peak at 18 h. Furthermore, data from p27 co-precipitation experiments revealed that in hypoxic cell lysates p27 co-precipitated with higher amounts of CDK2 and cyclin E than in aerobic controls ( Figure 6B ). Taken together these results Figure 2 Detection of pRB in cell lysates from hypoxic CV-1P cells. Whole-cell lysates were prepared from 24 h aerobic (A), 12-(12H), 18-(18H), or 24-(24H) h hypoxic cells separated on a 6% SDS-gel and subjected to immunoblotting as described in Materials and methods. pRB is detected as a doublet consisting of the faster-migrating, hypophosphorylated (indicated by the arrow on the right) and slower-migrating hyperphosphorylated forms Figure 3 (A) Histone H1-directed kinase activity. Cells were subjected to 18 (18H) or 24 (24H) h of hypoxia or maintained under aerobic conditions (A), lysed and used for the kinase assay as described in Materials and methods. Total cyclin-dependent kinase activity was determined by scintillation counting of the ®lter bound counts. The summary data from ®ve samples from two independent experiments are presented as the amount of activity relative to aerobic control. Error bars represent standard deviations for ®ve samples from two independent experiments. (B) pRB-directed CDK4 kinase activity. GST-pRB 1-928 was mixed with CDK4 immunoprecipitates from the respective cell lysates for the kinase reaction. The proteins were separated on a 6% SDS-gel and phosphorylated pRB visualized by autoradiography. The amount of incorporated 32 P-label quanti®ed by phosphorimager analysis is expressed as a per cent of the aerobic control and indicated below each lane (% AER). This percentage was calculated by dividing the amount of incorporated label (as quanti®ed phosphorimager analysis) for each of the hypoxic cultures by the amount of incorporated label for a parallel culture of aerobically-maintained cells (designated 100%) and multiplying by 100 support the notion that p27 plays a role in the inhibition of CDK2 activity induced by hypoxia. They also indicate that during hypoxia there is an increased amount of p27 available for binding with cyclin E-CDK2 complexes.
In order to determine the presence of any active cyclin E-CDK2 complexes in hypoxic cells, we removed p27 bound cyclin-CDK2 complexes from the cell lysates by pre-clearing using p27 immunoprecipitation. These pre-cleared lysates were then used for CDK2 immunoprecipitation followed by immunoblot analysis with cyclin E antibodies. As expected, preclearing of the lysate with p27 antibody left abundant cyclin E available for co-precipitation with CDK2 in aerobic lysates, but did not leave a precipitable amount of cyclin E in hypoxic lysates ( Figure 6C ). This further strengthens the argument that virtually all of the available cyclin E in hypoxic cells is associated with p27 in inactive cyclin E-CDK2-p27 complexes and that there are no detectable active cyclin E-CDK2 complexes in hypoxic cells. This indicates that most of cyclin E-CDK2 complexes present in hypoxic cells are associated with the p27 inhibitor. We conclude from these data that p27 plays a central role in the inhibition of cyclin E-CDK2 activity during the cell response to hypoxia, thus contributing towards accumulation of hypophosphorylated pRB.
pRB-directed phosphatase activity is speci®cally induced during hypoxia
Previous studies in our laboratory have shown that the conversion of pRB into its active, growth suppressive, hypophosphorylated form in late M phase is due to the action of a pRB-directed protein phosphatase (PP1) (Ludlow et al., 1993a; . To establish if hypoxia induces speci®c activation of PP1 leading to the conversion of pRB from a hyper-to hypo-phosphorylated form, pRB-directed phosphatase assays were performed using lysates from cells exposed to hypoxia for up to 48 h ( Figure 7A ). The summary data from four independent experiments (0 ± 48 h time course) indicate that there is a 30 ± 50% increase in pRB-directed phosphatase activity which peaks at 18 h of hypoxia relative to aerobic controls ( Figure 7B ). These data are consistent with conversion of hyper-to hypo-phosphorylated pRB in vivo as detected by immunoblotting (Figure 2 ; Krtolica and Ludlow, 1996; Ludlow et al., 1993b) . pRB-directed phosphatase activity remains elevated by 20% relative to aerobic controls after 24 h and returns to aerobic levels by 48 h of hypoxia. For comparison, cells arrested in G 1 by serum starvation, which demonstrate very little pRB-directed phosphatase activity by this assay (Ludlow et al., 1993a) , exhibit approximately 50% less PP1-mediated pRB dephosphorylation than cells arrested in G 1 by hypoxia.
To test whether the hypoxia-induced increase in the pRB-directed phosphatase activity is due to an overall elevation of PP1 activity in the cell, we measured phosphatase activity using phosphorylase a as a substrate. Phosphorylase a is phosphorylated on a single serine residue (Brautigan and Shriner, 1988 ) and used as the standard substrate for monitoring Figure 5 (A) Histone H1-directed CDK activity in CDK2 and cyclin E immunoprecipitates. Immunoprecipitations with CDK2 and cyclin E antibodies and kinase assays were performed as described in Materials and methods.
32 P-labeled phosphorylated histone H1 was visualized by autoradiography. The amount of incorporated 32 P-label quanti®ed by phosphorimager analysis is expressed as a per cent of the aerobic control and indicated below each lane. (B) pRB-directed CDK2 activity. Immunoprecipitations with CDK2 antibodies were mixed with GST-pRB 1-928 and kinase assays were performed as described in Materials and methods. Whole-cell lysates were prepared from 24-(24A) and 48-(48A) h aerobic, 12-(12H), 18-(18H), 24-(24H), 48-(48H) h hypoxic cells, separated on a 12% SDS-gel and subjected to immunoblotting as described in Materials and methods. Decreased expression in 48A compared to 24A controls re¯ects growth arrest resulting from cultures forming a monolayer enzymatic dephosphorylation by PP1 and the type 2A serine/threonine protein phosphatase (PP2A). However, in CV-1P cell lysate greater than 90% of the phosphatase activity is attributed to PP1 (Nelson and Ludlow, unpublished observations) . The results obtained showed that total phosphatase activity after 18 and 24 h of hypoxia remained unchanged relative to aerobic controls ( Figure 8A ). The levels of PP1 isoforms in CV-1P cell lysates remained relatively constant during hypoxia ( Figure 8B ), suggesting that the observed increase in pRB-directed phosphatase activity was not due to an increase in PP1 abundance.
Discussion
We report here that during exposure to hypoxia, monkey kidney CV-1P cells undergo cell cycle arrest with an accumulation predominantly in the G 1 phase of the cycle (Figure 1 ). Indeed, the low level of DNA synthesis which can be observed during hypoxia may result from a population of cells in the ®nal stages of S which ®nish synthesizing DNA. Alternatively, a population of cells at the G 1 /S border already committed to entering S may do so more slowly over time during hypoxia. In addition, we cannot rule out Figure 6 (A) Co-precipitation of CDK2 complexes from hypoxic and aerobic cell lysates using CDK2 and cyclin E antibodies. Cells were maintained under aerobic conditions (A) or for 18-(18H) or 24-(24H) h in hypoxia, lysed and subjected to immunoprecipitation with CDK2 or cyclin E antibodies as described in Materials and methods. Western blots were probed with cyclin E, CDK2, or p27 speci®c antibodies as indicated to the left of each panel. (B) Co-precipitation of CDK2 complexes from hypoxic and aerobic cell lysates using p27 antibody. Cells were maintained under aerobic conditions (A) or for 18-(18H) or 24-(24H) h in hypoxia, lysed and subjected to immunoprecipitation with p27 antibodies as described in Materials and methods. Western blots were probed for cyclin E, CDK2, and p27 as indicated to the left of each panel. (C) Co-precipitation of CDK2 complexes from hypoxic and aerobic cell lysates pre-cleared with p27 antibody. Cells were maintained under aerobic conditions (A) or for 18-(18H) or 24-(24H) h in hypoxia, lysed and subjected to p27 immunodepletion followed by immunoprecipitation with CDK2 antibody as described in Materials and methods. Western blots were probed for cyclin E, CDK2, and p27 as indicated to the left of each panel Figure 7 pRB-directed phosphatase activity assays: (A) Phosphorimage. Lysates from cells maintained under aerobic or hypoxic (18 h) conditions were added (25 mg) to 32 P-labeled immunocomplexed pRB, and incubated at 308C for 30 min (assay samples, (A) or mixed immediately with SDS ± PAGE sample buer (control samples, C). The phosphatase assay was terminated by addition of SDS-PAGE sample buer and proteins were separated on 8% SDS-polyacrylamide gels, dried and exposed to a phosphorimager screen. Each sample was prepared and run in duplicate. (B) Per cent increase in pRBdirected phosphatase activity in hypoxia relative to aerobic control. Cells were subjected to 18-(18H), 24-(24H) or 48-(48 h) h of hypoxia or maintained under aerobic conditions and after lysis subjected to phosphatase assay as described above. The summary data from four experiments are presented as the average increase in pRB-speci®c phosphatase activity relative to aerobic controls. Error bars represent standard error of the means for eight samples from four independent experiments the possibility that hypoxia also induces a G 2 /M block. The slight increase in the percentage of hypoxic cells in G 2 /M presented here (0 ± 10% in ®ve independent experiments), together with our previous report that hypoxia can growth arrest cells at dierent stages of the cell cycle (Ludlow et al., 1993b) , would support this notion.
Concomitant with cell cycle arrest is the accumulation of pRB in its hypophosphorylated, growth suppressive form (Figure 2 ). It has been postulated that pRB represents a major molecular switch which determines if a cell is going to proceed through another cell division cycle. We present evidence that hypoxia induces pRB hypophosphorylation as a result of synergy between increased pRB-directed speci®c phosphatase activity and inhibition of both CDK4 and CDK2 activity (Figures 3, 5 and 7) . Thus, there is an increased activity to remove phosphates from pRB and a decreased activity to put phosphates on. Accompanying this induction of phosphatase activity and CDK inhibition is a decrease in cyclin D, CDK4 and cyclin E abundance (Figures 4 and 6 ) and a dramatic increase in p27 protein abundance (Figure 6) . Furthermore, we have demonstrated that p27 associates with CDK2 complex under hypoxic and not aerobic conditions in this system, thus mediating inhibition of CDK2 activity (Figure 6 ). When comparing the immunoblots of the CDK2 band from p27 immunoprecipitates with the corresponding CDK2 band in CDK2 precipitates, an association of p27 with both faster and slower migrating forms of CDK2 ( Figure 6B ) can be observed. We believe that the faster migrating form of CDK2 corresponds to the Thr160 phosphorylated, active 33 kD catalytic subunit, while the slower form represents CDK2 which lacks this activating phosphate on Thr160 (Fang et al., 1996; Gu et al., 1992) . It has been demonstrated that p27 can inhibit both the process of CDK2 activation by CDKactivating kinase (CAK) and the kinase activity of cyclin-CDK2 complexes previously assembled and activated in the cell (Reynisdottir and MassagueÂ , 1997; Polyak et al., 1994) . Thus, it is not surprising to ®nd that p27 binds to both forms of CDK2 during hypoxia. Taken together, our results indicate that there is some similarity between cell cycle arrest by hypoxia and that seen with serum starvation ± the observed decrease in cyclin/CDK activities toward pRB. However, there is at least one fundamental dierence ± the observed increase in pRB-directed phosphatase activity.
There are only a few possible mechanisms which may directly link hypoxia to the described induction of cell cycle arrest. One possibility is that p27 is the ®rst target of hypoxia-induced cell cycle arrest. An increase in p27 abundance and its subsequent inhibition of CDK2 activity has been proposed as the mode of action for multiple anti-mitogenic signals . A second possibility is that hypoxia inhibits CDK4/6 activity, an early G 1 event, which would then lead to a subsequent shut down of all downstream cell cycle events and growth arrest. This would imply that hypoxia acts at the same point of the cell cycle as multiple growth factors whose presence is necessary for cyclin D expression and consequently, CDK4/6 kinase activity. Our results support the notion that hypoxia directly aects both CDK4 and CDK2 activity. This type of regulation has been recently observed in TGFb-induced cell cycle arrest (Reynisdottir et al., 1995) . Although not addressed here, downregulation of CDK activities may involve hypoxia-induced dierences in CDK transcription rates. For example, our observed decrease in CDK4 gene transcription. In contrast, the amount of CDK2 remains relatively constant in these cells, suggesting perhaps that transcription of this gene is relatively unaected by hypoxia.
While the above mentioned possibilities involve phosphorylation of pRB as a downstream event, the data presented above do not directly address the question of whether hypoxia induces pRB dephosphorylation as a means to growth arrest cells. While an attractive hypothesis, this presumes that pRB is a major regulator in hypoxia-induced cell cycle arrest. In support of this notion, preliminary experiments carried out in this laboratory show that cells which do not express pRB appear to be less capable of growth arresting during hypoxia. Functional inactivation of the growth suppressive activity of hypophosphorylated pRB, perhaps by complex Figure 8 (A) Eect of hypoxia on phosphorylase a-directed phosphatase activity. Cells were subjected to 18-(18H) or 24-(24H) h of hypoxia or maintained under aerobic conditions (A), lysed, and these lysates used for the phosphorylase a phosphatase assay as described in Materials and methods. Results are presented as percent release of 32 P-counts for equivalent amounts of protein per sample. Error bars represent standard error of the mean for three samples. (B) Immunoblot analysis of hypoxia cell lysates for a, g1, g2 and d isoforms of protein phosphatase type 1. Cells were subjected to 12-(12H), 18-(18H) or 24-(24H) h of hypoxia or maintained under aerobic conditions (A) and lysed. Equal amounts of protein were separated on 10% SDSpolyacrylamide gels and subjected to immunoblotting as described in Materials and methods formation with viral tumor antigens (Ludlow, 1993c Figure 1B ). This may suggest that additional mechanism(s) not in¯uenced by hypoxia play a role in cell growth of this subpopulation of cells.
We are currently investigating the mechanism(s) involved in the phosphatase activation during hypoxia. In this regard, a recently discovered PP1-associated protein, originally designated R 111 (Jagiello et al., 1995) which appears to be the recently cloned and characterized PNUTS protein (Allen et al., 1998) , may function to speci®cally activate PP1 to dephosphorylate pRB. Support for this comes from our recent report in which R 111 was found in fractions of mitotic cell lysate containing active pRB phosphatase activity ), yet could not be detected in G 1 cell lysate fractions known to contain PP1, but having little pRB-directed phosphatase activity (Krucher and Ludlow, unpublished observations). We can speculate that hypoxia facilitates association between R 111 and PP1, thereby increasing catalytic activity towards pRB. Since we do not observe any signi®cant change in PP1 abundance during hypoxia, modulation of speci®c activity by virtue of a PP1-associated protein is an attractive hypothesis. Since molecular reagents to PNUTS/R 111 are now available, we are currently pursuing this avenue of investigation. Alternatively, changes in PP1 catalytic activity may be due to the alternation of its phosphorylation state by cyclin-CDK complexes shown to aect PP1 activity (Dohadwala et al., 1994; Villa-Moruzzi, 1992) . Hypoxia-induced decrease in cyclin-CDK activities, as presented above, may in this way directly alter PP1 activity.
Finally, although not investigated here, pRB can also repress transcription of RNA polymerases I (Cavanaugh et al., 1995) and III (White et al., 1996) which transcribe genes encoding the essential components of the protein synthesis machinery (rRNAs, tRNAs etc.). This observed eect may suggest that pRB monitors cell size and initiation of DNA replication by in¯uencing total cellular biosynthesis through its repression of all three nuclear RNA polymerases, in addition to its speci®c repression of the early S phase genes (Bartek et al., 1996) . If con®rmed, and taken together with our current ®ndings, this may explain the mechanism for the inhibitory eect of hypoxia on general RNA and protein synthesis which has been a long-standing observation in hypoxia research (Heacock and Sutherland, 1990) , and would implicate pRB as having a major role in two of the most prominent eects of hypoxia ± cell cycle arrest and general inhibition of biosynthesis.
Materials and methods
Cell growth conditions
CV-1P, a continuous line of monkey kidney epithelial cells, was maintained in Dulbecco's modi®ed Eagle's medium (DMEM, Gibco ± BRL, Life Technologies, Gaithersburg, MD) containing 10% newborn bovine serum at 378C in a humidi®ed, 5% CO 2 -containing atmosphere. With the exception of one set of 48 h aerobic control cultures (Figure 4) , cells never exceeded 70% con¯uency for analysis.
Establishing hypoxic cultures
Hypoxic conditions were established by placing cell cultures in sealed chambers maintained at 378C followed by repeated exchange with 95% N 2 : 5% CO 2 over a 2 h period. Oxygen levels were measured in the conditioned medium at the end of each experiment using an oxygen microelectrode (Microelectrodes, Inc., Bedford, NH) and were consistently found to range between 0.5 and 1.5% oxygen. Measurement of glucose levels in conditioned medium from aerobic and hypoxic cell cultures revealed that under all conditions glucose remained above 80% of the amount present in the fresh medium (Sigma Diagnostics Glucose, Procedure No. 510, Sigma, St. Louis, MO). There was no induction of cell death under hypoxic conditions as determined by trypan blue exclusion and in situ apoptosis detection using a commercially available kit (Apop Tag, S7100-KIT; Oncor, Gaithersburg, MD). For pRB and phosphorylase a dephosphorylation assays, cyclin-dependent kinase assays, immunoprecipitations, SDS-polyacrylamide gel electrophoresis and¯ow cytometry samples, CV-1P cells were plated at 8610 5 ± 10 6 cells per 100 mm plate for 16 ± 18 h prior to establishing hypoxic conditions. For cell counting, [ 3 H]thymidine incorporation and colony forming assays, 2610 5 cells per 60 mm dish were plated 4 ± 5 h prior to establishment of hypoxia.
Cell counting
CV-1P cells were plated at 2610 5 cells per 60 mm culture plate. One half of the total number of plated cultures were made hypoxic as described above and maintained at 378C. The remaining number of plates served as the aerobic controls. At the end of the designated time interval, adherent cells were trypsinized to remove them from the plates and, following viability determination by trypan blue exclusion, counted on a Coulter counter (Model ZM, Coulter Electronics, Inc., Miami, FL). Each count was repeated twice and each condition was performed in duplicate within each experiment.
Colony forming assays
CV-1P cells were cultured and treated as described above for cell counting. At the desired time, adherent cells were trypsinized to remove them from the plates, viable cell number was determined by counting trypan-blue excluding cells in a hemacytometer, and these cells were re-plated under aerobic conditions at 500 and 100 cells/60 mm dish. After 10 days, the medium was discarded from all ®ve plates of each set and the formed cell colonies were then ®xed and stained for 10 min in 0.125% (w/v) crystal violet in 100% ethanol. Stained plates were washed with water and air dried for 24 h before counting.
Flow cytometry and DNA histogram analysis
Aerobic and hypoxic cells were harvested by trypsinization and low speed centrifugation. The resulting cell pellet was then ®xed in ice cold 70% ethanol and stored at 48C until ow cytometric analysis. Fixed cells (at least 5610 5 cells) were then centrifuged (55 g, 10 min), resuspended in 1 mL of phosphate buered saline containing 1 mg/ml RNase A, and incubated at room temperature for 30 min. Propidium iodide was added to a ®nal concentration of 10 mg/ml, and ow cytometry was performed on a Pro®le I¯ow cytometer (Coulter Counter, Coulter Electronics, Inc., Miami, FL).
DNA histogram analysis was performed using the MultiCycle AV DNA software package (Phoenix Flow Systems, Inc., San Diego, CA).
[
H]thymidine incorporation
Aerobic and hypoxic cells (2610 5 ) adhered to the bottom of 60 mm dishes were labeled with 3 H-thymidine (2 uCi/ ml). Following incubation at 378C for 45 min, the labeled cells were trypsinized o the plate and resuspended in a total of 10 ml of serum-containing medium. One half of the total volume of cell suspension (5 ml) was subjected to cell counting as described above. The remaining volume of cells was pelleted by low speed centrifugation and lysed on ice with 1 ml of RIPA buer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mm EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS)). Immediately thereafter, this lysate was precipitated on ice for 30 min with 10% trichloroacetic acid (TCA). The precipitable counts were recovered by ®ltration through GF/A glass ®lters (Whatman, Maidstone, UK), washed extensively with 5% TCA, rinsed with 95% ethanol, then allowed to air dry before quanti®cation by liquid scintillation spectroscopy. Each condition was repeated in triplicate for each experiment.
SDS-polyacrylamide gel electrophoresis and immunoblotting
All cells were lysed for 15 min at 48C in EBC buer (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40) containing 10 mg/ml of the protease inhibitors aprotinin, leupeptin, and phenylmethylsulfonyl¯uoride (PMSF). The lysates were cleared by centrifugation at 14 000 g for 10 min. Electrophoresis was performed in 7.5%, 8%, 10% or 12% SDS-polyacrylamide gels (Laemmli, 1970) using 100 mg of total cell protein for each sample lane (Bradford, 1976) . After electrophoresis, the proteins were transferred to nitrocellulose paper in buer containing 25 mM Tris-HCl, 192 mM glycine, 20% v/v methanol, and 0.01% SDS, pH 8.5 (Towbin et al., 1979) . Residual protein binding sites on the nitrocellulose were blocked by incubation for 30 min in TBST (25 mM Tris-HCl, pH 8.0 150 mM NaCl, 0.5% Tween-20) containing 4% non-fat dry milk. Next, the nitrocellulose was incubated in TBST containing 2% non-fat dry milk containing either 0.033 mg/ml of antibody to pRB (PMG3-245; PharMingen, San Diego, CA), a 1 mg/ml concentration of cyclin D antibody (06-137; Upstate Biotechnology, Inc. (UBI), Lake Placid, NY), a 1:5 dilution of antibody to cyclin E (HE 12; provided by Ed Harlow and Nick Dyson, Massachusetts General Hospital, Boston, MA), a 1:1000 dilution of antibody to PP1a (rabbit polyclonal; a gift from Emma Villa-Moruzzi, Pisa, Italy), a 1:500 dilution of antibody to PP1 g1 , PP1 g2 , or PP1d (rabbit polyclonal; obtained from Brain E Wadzinsky, Vanderbilt University, Nashville, TN), 1 mg/ml of anti-CDK2 (rabbit polyclonal, 06-505; UBI), 1 mg/ml anti-CDK4 (SC-260; Santa Cruz Biotechnology Inc., Santa Cruz, CA), 2 mg/ml anti-p21 (15091A; PharMingen), or 0.125 mg/ml of anti-p27 (K25020; Transduction Laboratories, Inc., Lexington, KY). Following three washes of 10 min each with TBST, the nitrocellulose was probed with horse-radish peroxidase-conjugated anti-IgG (Promega, Madison, WI) and developed using chemiluminescence detection (Pierce, Rockford, IL) according to the manufacturer's instructions.
Preparation of [
32 P]pRB substrate and pRB-directed phosphatase activity assays
To assay pRB-directed phosphatase activity, 32 P-labeled pRB substrate was prepared by immunoprecipitation with monoclonal antibody to pRB, PMG3-245 (PharMingen), from 32 P-labeled CV-1P cells as described previously . For the source of enzyme, cells were plated at 8610 5 cells per 100 mm plate 16 ± 18 h prior to beginning the establishment of hypoxia. At the end of the hypoxic treatment (18, 24 or 48 h) cells were washed three times with 20 mM imidazole, pH 7.0, 150 mM NaCl, and lysed by sonication in the same buer supplemented with 14 mM 2-mercaptoethanol and the following protease inhibitors: 1 mM benzamidine, 50 mM TPCK, 50 mM TLCK, 50 mM leupeptin, and 1 mM pepstatin. Lysates from hypoxic or aerobic cells, normalized for protein content and volume, were incubated with 32 P-labeled immunoprecipitated pRB for 30 min at 308C (assay samples) or mixed immediately with SDS ± PAGE sample buer (control samples). Phosphatase reactions were terminated by the addition of SDS ± PAGE sample buer and boiling. Proteins were separated on 8% SDS ± polyacrylamide gels. Gels were ®xed, dried and activity was measured by assessing incorporation of pRB radiolabel relative to controls and quanti®ed using a phosphorimager with ImageQuant Software (Molecular Dynamics, Sunnyvale, CA). Activity is measured as the percent decrease in pRB band densities in assay lanes compared to control lanes.
Phosphorylase a-directed phosphatase activity assays
Cell plating, treatment and lysis were performed as described above. [
32 P]phosphorylase a was prepared (Cohen et al., 1988) and phosphorylase phosphatase activity measured as the release of TCA soluble counts from [
32 P]phosphorylase a as previously described .
pRB substrate preparation and kinase assays Full-length pRB fused to glutathione-S-transferase (GSTpRB ) was expressed and puri®ed from E. coli. strain BL21pLys using glutathione-Sepharose beads as described recently (Zarkowska and Mittnacht, 1997) . was then eluted from the beads using excess glutathione, and estimates of the amount of eluted GST-pRB were made by comparing silverstained band intensities with those of known quantities of bovine serum albumin. Approximately 2 mg of GSTpRB was then mixed with CDK2 or CDK4 immunoprecipitates from aerobic and hypoxic-treated cells in kinase buer (20 mM MOPS, pH 7.2, 25 mM bglycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol) containing protease inhibitors (10 mg/ml of aprotinin, leupeptin, and PMSF). Following the addition of 1 mCi [ 32 P]ATP and incubation at 308C for 30 min, the reactions were terminated by adding SDS-sample buer and boiling. Negative control reactions using pre-immune rabbit serum and puri®ed mouse IgG immunoprecipitations revealed undetectable levels of substrate phosphorylation.
Immunoprecipitation and coprecipitation of CDK4 and CDK2 complexes
Cell lysates were prepared by scraping cells from the plate into ice cold kinase buer (20 mM MOPS, pH 7.2, 25 mM b-glycerol phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol) containing protease inhibitors (10 mg/ml of aprotinin, leupeptin and PMSF) followed by sonication. Lysates from hypoxic or aerobic cells containing 500 mg of total protein were normalized to the same volume (approximate protein concentration of 1 mg/ ml) and following a 1 h pre-clearing with Staphylococcus protein A-Sepharose beads, immunoprecipitated for 1.5 to 2 h with primary antibody at 48C. Next, 50 ml of a 1:1 slurry of protein A-beads in the kinase buer was added and the precipitates incubated for an additional hour. After three washes with kinase buer, precipitates were either immediately used for the kinase assay or prepared for SDS ± PAGE by the addition of 50 ml of 3X SDS ± PAGE sample buer (6% SDS, 30% (v/v) glycerol, 0.3 M dithiothreitol, 0.36 M Tris-HCl, pH 6.8) and then boiled. The following rabbit polyclonal antibodies were used for these immunoprecipitations: anti-CDK2 (06-505; UBI), anti-CDK4, anti-cyclin E, and anti-p27 and Sc-528, respectively; Santa Cruz Biotechnology).
Cyclin-dependent kinase activity assay
Cell lysates were prepared as described for immunoprecipitations. Assays were performed according to manufacturer's instructions (Cyclin-dependent Kinase Assay Kit, 17-137; UBI) in the presence of the following kinase inhibitors: protein kinase C and protein kinase A inhibitor peptides and the calmodulin-dependent kinase inhibitor compound R24570. Reactions were terminated by cooling the mixtures in an ice water bath. Two thirds of the reaction mixture was transferred to phosphocellulose ®lters (Whatman P81) and, after extensive washing with 0.75% phosphoric acid and rinsing with acetone, the ®lters were air-dried and subjected to scintillation counting. The remaining one third of the sample was mixed with SDS ± PAGE sample buer, boiled, and proteins separated on 12% SDS-polyacrylamide gels. Gels were ®xed, dried and activity was measured by assessing incorporation of radiolabel into histone H1 or pRB relative to controls and quanti®ed using a phosphorimager with ImageQuant Software (Molecular Dynamics, Sunnyvale, CA). We observed no signi®cant dierence between the relative levels of activity obtained by direct scintillation counts and phosphorimager analysis.
